Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis Kajumo

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Virology|June 17, 2006
An anti-CCR5 monoclonal antibody and small molecule CCR5 antagonists synergize by inhibiting different stages of human immunodeficiency virus type 1 entryDiana Safarian, Xavier Carnec, Fotini Tsamis, et al.
Journal of Virology|May 18, 2007
Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralizationEmilia Falkowska, Francis Kajumo, Edie Garcia, et al.
Journal of Virology|March 20, 2009
Residues in a highly conserved claudin-1 motif are required for hepatitis C virus entry and mediate the formation of cell-cell contactsLisa Cukierman, Laurent Meertens, Claire Bertaux, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2004
CD81 is an entry coreceptor for hepatitis C virusEmmanuel G Cormier, Fay Tsamis, Francis Kajumo, et al.
Journal of Virology|December 4, 2003
Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1Julie Dumonceaux, Emmanuel G Cormier, Francis Kajumo, et al.
Journal of Virology|April 15, 2003
Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entryFotini Tsamis, Svetlana Gavrilov, Francis Kajumo, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Virology|June 17, 2006
An anti-CCR5 monoclonal antibody and small molecule CCR5 antagonists synergize by inhibiting different stages of human immunodeficiency virus type 1 entryDiana Safarian, Xavier Carnec, Fotini Tsamis, et al.
Journal of Virology|May 18, 2007
Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralizationEmilia Falkowska, Francis Kajumo, Edie Garcia, et al.
Journal of Virology|March 20, 2009
Residues in a highly conserved claudin-1 motif are required for hepatitis C virus entry and mediate the formation of cell-cell contactsLisa Cukierman, Laurent Meertens, Claire Bertaux, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2004
CD81 is an entry coreceptor for hepatitis C virusEmmanuel G Cormier, Fay Tsamis, Francis Kajumo, et al.
Journal of Virology|December 4, 2003
Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1Julie Dumonceaux, Emmanuel G Cormier, Francis Kajumo, et al.
Journal of Virology|April 15, 2003
Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entryFotini Tsamis, Svetlana Gavrilov, Francis Kajumo, et al.
Pageof 1